CN104788586B - Chondroitin sulfate strontium and preparation method thereof - Google Patents

Chondroitin sulfate strontium and preparation method thereof Download PDF

Info

Publication number
CN104788586B
CN104788586B CN201510150350.0A CN201510150350A CN104788586B CN 104788586 B CN104788586 B CN 104788586B CN 201510150350 A CN201510150350 A CN 201510150350A CN 104788586 B CN104788586 B CN 104788586B
Authority
CN
China
Prior art keywords
chondroitin sulfate
cartilage
strontium
hours
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510150350.0A
Other languages
Chinese (zh)
Other versions
CN104788586A (en
Inventor
马粉波
唐斌
温春毅
李慧丽
葛永梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southwest University of Science and Technology
Original Assignee
Southwest University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southwest University of Science and Technology filed Critical Southwest University of Science and Technology
Priority to CN201510150350.0A priority Critical patent/CN104788586B/en
Publication of CN104788586A publication Critical patent/CN104788586A/en
Application granted granted Critical
Publication of CN104788586B publication Critical patent/CN104788586B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present inventor is related to a kind of chondroitin sulfate strontium and preparation method thereof.The molecular formula of the chondroitin sulfate strontium is:H2O(C14H19NSrO14S)x, wherein, x is 60~100 integer.The problem of above-mentioned chondroitin sulfate strontium can not only avoid causing blood vessel and the calcium at capillary position to stockpile and cause petechiae and hemotoncus, additionally it is possible to preferable auxiliary treatment osteoporosis and osteoarthritis.

Description

Chondroitin sulfate strontium and preparation method thereof
Technical field
The invention belongs to biological technical field, more particularly to a kind of chondroitin sulfate strontium and preparation method thereof.
Background technology
Chondroitin sulfate is a kind of glutinous polysaccharose substance extracted from animal cartilage, mainly by D-Glucose aldehydic acid and N- Acetyl-D-amino galactolipin is formed.It has protective effect to bone, can prevent bone and is hardened to become fragile, prevent further calcium Hardening, bone is kept certain pliability, contribute to the recovery of osteoproliferation, in Bone Defect Repari, the preventing and treating etc. of arthropathy Have the function that important.
The method of tradition extraction chondroitin sulfate mainly has alkali carries enzymatic isolation method, alkaline extraction, ultrasonic assistant method and acetic acid to carry Follow the example of, the chondroitin sulfate that these conventional methods are prepared mainly exists in the form of sodium chondroitin sulfate, and chondroitin sulfate Element is better than sodium to the affinity of calcium, after use, easily causes blood vessel and the calcium at capillary position to stockpile and cause petechiae and blood It is swollen, effect is poor to be prevented to osteoporosis and osteoarthritis.
The content of the invention
In consideration of it, being necessary to provide a kind of chondroitin sulfate strontium, the chondroitin sulfate strontium can avoid blood vessel and blood capillary Petechiae and the problem of hemotoncus caused by the calcium of pipe portion position stockpiles, and being capable of preferably auxiliary treatment osteoporosis and Bones and joints It is scorching.
In addition, also provide a kind of preparation method of chondroitin sulfate strontium.
A kind of chondroitin sulfate strontium, the molecular formula of the chondroitin sulfate strontium is H2O(C14H19NSrO14S)x, wherein, x is 60~100 integer.
A kind of preparation method of chondroitin sulfate strontium, comprises the following steps:
The aqueous solution of sodium chondroitin sulfate is crossed into cation exchange resin column, when the pH value of efflux is changed into 4.5 from neutrality ~5 start to collect efflux, until the pH value of efflux is changed into 6.5~7, stop collecting;
The pH value for the efflux collected is adjusted to 6~6.5, then adds soluble strontium salt, stirring and dissolving 20 minutes ~60 minutes, through standing reaction 3 hours~5 hours, reaction solution is obtained, wherein, the water-soluble strontium salt and the chondroitin sulfate The mass ratio of plain sodium is 0.4:1~0.8:1;And
The aqueous solution that the ethanol that weight/mass percentage composition is 90%~95% is added in the reaction solution obtains mixed liquor, and The weight/mass percentage composition of ethanol in the mixed liquor is 60%~65%, and the mixed liquor is stood, then filtered, is divided Minor is H2O(C14H19NSrO14S)xChondroitin sulfate strontium, wherein, x be 60~100 integer.
In one of the embodiments, the cationic ion-exchange resin in the cation exchange resin column and the sulfuric acid are soft The mass ratio of ossein sodium is 3:1~4:1.
In one of the embodiments, in the aqueous solution of the sodium chondroitin sulfate, the quality of the sodium chondroitin sulfate Percentage composition is 5%~10%.
In one of the embodiments, the water-soluble strontium salt is strontium chloride or Strontium Ranelate.
In one of the embodiments, the time that the mixed liquor is stood is 12 hours~15 hours.
In one of the embodiments, in addition to suction filtration the step that the suction filtration thing obtained is cleaned and dried, it is described Cleaning and the step dried are:The suction filtration thing is cleaned using absolute ethyl alcohol, is then dried in vacuo 2 in 60 DEG C~80 DEG C Hour~4 hours.
In one of the embodiments, the preparation process of the sodium chondroitin sulfate is included:
It will be crushed after cartilage degreasing, obtain cartilage powder;
The cartilage powder is mixed with deionized water, then adds basifier, is stirred in 30 DEG C~40 DEG C to described soft Bone powder dissolves, and obtains Cartilage solution, wherein, the mass ratio of the basifier and the cartilage is 0.01:1~0.5:1, the alkali Agent is sodium hydroxide or sodium acid carbonate;
The pH value of the Cartilage solution is adjusted to 8~9, pancreatin is added, is digested 4 hours~5 hours in 40 DEG C~50 DEG C, then It is warming up to 80 DEG C~100 DEG C insulation reactions 2 hours~4 hours, it is filtered, obtain settled solution, the pancreatin and the cartilage Mass ratio be 0.0045:1~0.0055:1;And
The pH value of the settled solution is adjusted to 6~6.5, absolute ethyl alcohol is added and obtains mixture, and in the mixture Ethanol weight/mass percentage composition be 70%~75%, then filter, obtain sodium chondroitin sulfate.
In one of the embodiments, in the step of cartilage powder being mixed with the deionized water, it is described go from The quality of sub- water is 5 times~30 times of the quality of cartilage.
In one of the embodiments, it is by the step of cartilage degreasing:By the cartilage 80 in deionized water DEG C~100 DEG C of boilings 2 hours~3 hours, after removing the grease, in deionized water 80 DEG C~100 DEG C boilings 2 hours~ 4 hours, dried after cooling.
Above-mentioned chondroitin sulfate strontium is a kind of new chondroitin sulfate, and the strontium in the chondroitin sulfate strontium can pass through calcium channel Into cell, combined in the cell with relevant calcium binding site, have and promote skeleton development and osteoid to form and adjust bone The multiple action of metabolism, and strontium has the function that to promote Oesteoblast growth and suppresses osteoclast formation, on a cellular level, Strontium can be reduced bone reabsorption by osteoclast and by Gegenbaur's cell promoting bone growing, and chondroitin sulfate is to the parent of strontium and calcium It is suitable with ability, can avoid using it is traditional in the form of sodium chondroitin sulfate existing for chondroitin sulfate easily cause blood vessel And the calcium at capillary position stockpiles, and the problem of cause petechiae and hemotoncus, additionally it is possible to preferable auxiliary treatment osteoporosis And osteoarthritis.
Brief description of the drawings
Fig. 1 is the flow chart of the preparation method of the chondroitin sulfate strontium of an embodiment;
Fig. 2 represent be embodiment 1 chondroitin sulfate strontium concentration be respectively 0mmol/L, 1mmol/L, 3mmol/L and The relative expression quantity of interleukin (IL-1 β) mRNA during 5mmol/L;
Fig. 3 represent be embodiment 1 chondroitin sulfate strontium concentration be respectively 0mmol/L, 1mmol/L, 3mmol/L and The relative expression quantity of collagen (CollagenI) mRNA during 5mmol/L;
Fig. 4 represent be embodiment 1 chondroitin sulfate strontium concentration be respectively 0mmol/L, 1mmol/L, 3mmol/L and The relative expression quantity of memebrane protein (RANKL) mRNA during 5mmol/L;
When what Fig. 5 was represented is that the concentration of sodium chondroitin sulfate is respectively 0mmol/L, 1mmol/L, 3mmol/L and 5mmol/L Interleukin (IL-1 β) mRNA relative expression quantity;
When what Fig. 6 was represented is that the concentration of sodium chondroitin sulfate is respectively 0mmol/L, 1mmol/L, 3mmol/L and 5mmol/L Collagen (CollagenI) mRNA relative expression quantity;
When what Fig. 7 was represented is that the concentration of sodium chondroitin sulfate is respectively 0mmol/L, 1mmol/L, 3mmol/L and 5mmol/L Memebrane protein (RANKL) mRNA relative expression quantity.
Embodiment
Chondroitin sulfate strontium and preparation method thereof is made mainly in combination with drawings and the specific embodiments below further details of Explanation.
The chondroitin sulfate strontium of one embodiment, its molecular formula are H2O(C14H19NSrO14S)x, wherein, x is 60~100 Integer.
The chondroitin sulfate strontium can apply to Bone Defect Repari, arthropathy prevents etc..
Above-mentioned chondroitin sulfate strontium is a kind of new chondroitin sulfate, and the strontium in the chondroitin sulfate strontium can pass through calcium channel Into cell, combined in the cell with relevant calcium binding site, have and promote skeleton development and osteoid to form and adjust bone The multiple action of metabolism, and chondroitin sulfate is suitable to the affinity of strontium and calcium, avoids using traditional with chondroitin sulfate Chondroitin sulfate existing for the form of plain sodium easily causes blood vessel and the calcium at capillary position to stockpile, and causes petechiae and hemotoncus Problem.
As shown in figure 1, the preparation method of the chondroitin sulfate strontium of an embodiment, available for preparing above-mentioned chondroitin sulfate Strontium, the preparation method comprise the following steps:
Step S110:The aqueous solution of sodium chondroitin sulfate is crossed into cation exchange resin column, when efflux pH value therefrom Property be changed into 4.5~5 and start to collect efflux, until the pH value of efflux is changed into 6.5~7, stop collecting.
Wherein, sodium chondroitin sulfate can be bought by market;Can also be by voluntarily preparing.
Wherein, the preparation process of sodium chondroitin sulfate is as follows:It will be crushed after cartilage degreasing, obtain cartilage powder;Will be soft Bone powder mixes with deionized water, then adds basifier, is dissolved in 30 DEG C~40 DEG C stirrings to cartilage powder, it is molten to obtain cartilage Liquid;Wherein, the mass ratio of basifier and cartilage is 0.01:1~0.5:1;Basifier is sodium hydroxide or sodium acid carbonate;Adjust soft The pH value of bone solution adds pancreatin, digested 4 hours~5 hours in 40 DEG C~50 DEG C, then be warming up to 80 DEG C~100 DEG C to 8~9 Insulation reaction 2 hours~4 hours, it is filtered, obtain settled solution, the mass ratio of pancreatin and cartilage is 0.0045:1~ 0.0055:1;The pH value of settled solution is adjusted to 6~6.5, absolute ethyl alcohol is added and obtains mixture, and the ethanol in mixture Weight/mass percentage composition is 70%~75%, then filters, obtains sodium chondroitin sulfate.
Wherein, the pH value of Cartilage solution is adjusted into the step of 8~9, the use of reagent is the hydrochloric acid that concentration is 3~4mol/L The aqueous solution.
Wherein, in the step of cartilage powder being mixed with deionized water, the quality of deionized water is 5 times of the quality of cartilage ~30 times.
Wherein, the pH value of settled solution is adjusted into the step of 6~6.5, and concentration is the water of 3~4mol/L hydrochloric acid The pH value of solution regulation settled solution is to 6~6.5.
Wherein, it is by the step of cartilage degreasing:By cartilage, 80 DEG C~100 DEG C boilings 2 hours~3 are small in deionized water When, after removing grease, 80 DEG C~100 DEG C boilings 2 hours~4 hours in deionized water, dried after cooling.To ensure cartilage In grease be removed as far as possible.
In step S110, in the aqueous solution of sodium chondroitin sulfate, the weight/mass percentage composition of sodium chondroitin sulfate for 5%~ 10%.
In step S110, the mass ratio of cationic ion-exchange resin and sodium chondroitin sulfate in cation exchange resin column is 3:1~4:1.So that sodium is by complete exchange in sodium chondroitin sulfate.
Wherein, cationic ion-exchange resin is with styrene and divinylbenzene polymerization, through polymer prepared by sulfuric acid sulfonation. Cationic ion-exchange resin meets water and can be exchanged with each other certain electron ion in itself a certain active ion and water, that is, sends out Raw displacement reaction, removes soluble ion in water removal.
Step S120:The pH value for the efflux collected is adjusted to 6~6.5, then adds water-soluble strontium salt, stirring and dissolving 20 Minute~60 minutes, through standing reaction 3 hours~5 hours, obtain reaction solution.Wherein, water-soluble strontium salt and sodium chondroitin sulfate Mass ratio be 0.4:1~0.8:1.
Wherein, in step S120, the pH value of efflux of collection is adjusted to 6~6.5, the reagent used is that quality percentage contains Measure the aqueous solution of the strontium hydroxide for 10%~20%.The pH value for the efflux collected using the aqueous solution regulation of strontium hydroxide can The purity of product is influenceed to avoid introducing extraneous ion in preparation process.
Wherein, water-soluble strontium salt is strontium chloride or Strontium Ranelate.Strontium is as the important trace element in skeleton composition One of, cell can be entered by calcium channel, be combined in the cell with relevant calcium binding site, had and promote skeleton development and class The formation of sclerotin and the multiple action for adjusting Bone m etabolism.
Step S130:The aqueous solution for the ethanol that weight/mass percentage composition is 90%~95% is added in reaction solution, is mixed Liquid is closed, and the weight/mass percentage composition of the ethanol in mixed liquor is 60%~65%, and mixed liquor is stood, then filtered, is divided Minor is H2O(C14H19NSrO14S)xChondroitin sulfate strontium, wherein, x be 60~100 integer.
By making the weight/mass percentage composition of the ethanol in mixed liquor be 60%~65%, so that chondroitin sulfate strontium precipitates.
Wherein, in step S130, the time that mixed liquor is stood is 12 hours~15 hours.
Wherein, in addition to the step S130 suction filtration things for filtering to obtain the step cleaned and dried, clean and dry The step of be:Cleaned to filtering thing using absolute ethyl alcohol, be then dried in vacuo 2 hours~4 hours in 60 DEG C~80 DEG C.Tool Body, cleaned 3 times using absolute ethyl alcohol to filtering thing.
The preparation method of above-mentioned chondroitin sulfate strontium is simple, is raw material by using sodium chondroitin sulfate, and by using Above-mentioned steps, chondroitin sulfate strontium can be prepared, be a kind of new chondroitin sulfate;Strontium energy in the chondroitin sulfate strontium Cell is entered by calcium channel, combined in the cell with relevant calcium binding site, has and promotes skeleton development and osteoid shape Into the multiple action with regulation Bone m etabolism, and strontium has the function that to promote Oesteoblast growth and suppresses osteoclast formation, On cellular level, strontium can be reduced bone reabsorption by osteoclast and by Gegenbaur's cell promoting bone growing, and chondroitin sulfate It is suitable to the affinity of strontium and calcium so that upper chondroitin sulfate strontium not only avoid using traditional with sodium chondroitin sulfate Chondroitin sulfate existing for form easily causes blood vessel and the calcium at capillary position to stockpile, and the problem of cause petechiae and hemotoncus, And being capable of preferably auxiliary treatment arthritis and osteoporosis etc..And the preparation method of above-mentioned chondroitin sulfate strontium is prepared The high purity more than 95% of chondroitin sulfate strontium.And the raw material used in the preparation method of sulfuric acid ossein strontium is cartilage, source Extensively.
It is specific embodiment part below:
Embodiment 1
The preparation process of the chondroitin sulfate strontium of the present embodiment is as follows:
(1) preparation of sodium chondroitin sulfate:By animal cartilage in deionized water 80 DEG C of boilings 3 hours, after removing grease, 80 DEG C of boilings 4 hours in deionized water, are dried after cooling.
Crushed after cartilage degreasing, obtain cartilage powder, cartilage powder is placed in retort, add going for 5 times of cartilage Ionized water mixes, and is then 0.01 according to the mass ratio of sodium hydroxide and cartilage:1, sodium hydroxide is added, is stirred in 40 DEG C to soft Bone powder dissolves, and obtains Cartilage solution;Concentration be 3mol/L hydrochloric acid the aqueous solution adjust Cartilage solution pH value to 8, press It is 0.0045 according to the mass ratio of pancreatin and cartilage:1, pancreatin is added, is digested 4 hours in 40 DEG C, then be warming up to 80 DEG C of insulation reactions 4 Hour, it is filtered, obtain settled solution;Concentration is that the aqueous solution of 3mol/L hydrochloric acid adjusts the pH value of settled solution to 6, Add absolute ethyl alcohol and obtain mixture, and the weight/mass percentage composition of the ethanol in mixture is 70%, then filters, obtains sulfuric acid Chondroitin sodium.
(2) aqueous solution for the sodium chondroitin sulfate that weight/mass percentage composition is 8% is crossed into cation exchange resin column, works as outflow The pH value of liquid collects efflux since neutrality is changed into 4.5, until the pH value of efflux is changed into 7, stops collecting.Wherein, sun from The mass ratio of cationic ion-exchange resin and sodium chondroitin sulfate in sub-exchange resin post is 3:1.
(3) use quality percentage composition be 10% strontium hydroxide the pH value of efflux collected of aqueous solution regulation to 6, Then strontium chloride is added, stirring and dissolving 20 minutes, through standing reaction 3 hours, obtains reaction solution, wherein, strontium chloride is soft with sulfuric acid The mass ratio of ossein sodium is 0.4:1.
(4) aqueous solution that the ethanol that weight/mass percentage composition is 90% is added in reaction solution obtains mixed liquor, and mixed liquor In ethanol weight/mass percentage composition be 60%, by mixed liquor stand 12 hours, then filter, using absolute ethyl alcohol to filter thing Cleaning 3 times, then it is dried in vacuo 4 hours in 60 DEG C, it is H to obtain molecular formula2O(C14H19NSrO14S)60Chondroitin sulfate strontium.
The purity of the chondroitin sulfate strontium of the present embodiment is 95%.
Embodiment 2
The preparation process of the chondroitin sulfate strontium of the present embodiment is as follows:
(1) preparation of sodium chondroitin sulfate:By animal cartilage in deionized water 100 DEG C of boilings 2 hours, remove grease Afterwards, 100 DEG C of boilings 2 hours in deionized water, are dried after cooling.
Crushed after cartilage degreasing, obtain cartilage powder, cartilage powder is placed in retort, add going for 30 times of cartilage Ionized water mixes, and is then 0.5 according to the mass ratio of sodium acid carbonate and cartilage:1, sodium acid carbonate is added, is stirred in 30 DEG C to soft Bone powder dissolves, and obtains Cartilage solution;Concentration be 4mol/L hydrochloric acid the aqueous solution adjust Cartilage solution pH value to 9, press It is 0.0055 according to the mass ratio of pancreatin and cartilage:1, pancreatin is added, is digested 5 hours in 50 DEG C, then be warming up to 100 DEG C of insulation reactions It is 2 hours, filtered, obtain settled solution;Concentration be 4mol/L hydrochloric acid the aqueous solution adjust settled solution pH value to 6.5, add absolute ethyl alcohol and obtain mixture, and the weight/mass percentage composition of the ethanol in mixture is 75%, then filters, obtains Sodium chondroitin sulfate.
(2) aqueous solution for the sodium chondroitin sulfate that weight/mass percentage composition is 5% is crossed into cation exchange resin column, works as outflow The pH value of liquid collects efflux since neutrality is changed into 5, until the pH value of efflux is changed into 6.5, stops collecting.Wherein, sun from The mass ratio of cationic ion-exchange resin and sodium chondroitin sulfate in sub-exchange resin post is 4:1.
(3) use quality percentage composition be 20% strontium hydroxide the aqueous solution regulation collect efflux pH value to 6.5, strontium chloride is then added, stirring and dissolving 60 minutes, through standing reaction 5 hours, obtains reaction solution, wherein, strontium chloride and sulphur The mass ratio of aching and limp ossein sodium is 0.8:1.
(4) aqueous solution that the ethanol that weight/mass percentage composition is 95% is added in reaction solution obtains mixed liquor, and mixed liquor In ethanol weight/mass percentage composition be 65%, by mixed liquor stand 15 hours, then filter, using absolute ethyl alcohol to filter thing Cleaning 3 times, then it is dried in vacuo 2 hours in 80 DEG C, it is H to obtain molecular formula2O(C14H19NSrO14S)80Chondroitin sulfate strontium.
The purity of the chondroitin sulfate strontium of the present embodiment is 98%.
Embodiment 3
The preparation process of the chondroitin sulfate strontium of the present embodiment is as follows:
(1) preparation of sodium chondroitin sulfate:By animal cartilage in deionized water 90 DEG C of boilings 2.5 hours, remove grease Afterwards, 90 DEG C of boilings 3.5 hours in deionized water, are dried after cooling.
Crushed after cartilage degreasing, obtain cartilage powder, cartilage powder is placed in retort, add going for 20 times of cartilage Ionized water mixes, and is then 0.2 according to the mass ratio of sodium hydroxide and cartilage:1, sodium hydroxide is added, is stirred in 35 DEG C to soft Bone powder dissolves, and obtains Cartilage solution;Concentration be 4mol/L hydrochloric acid the aqueous solution adjust Cartilage solution pH value to 8, press It is 0.0050 according to the mass ratio of pancreatin and cartilage:1, pancreatin is added, is digested 4 hours in 50 DEG C, then be warming up to 90 DEG C of insulation reactions 3 Hour, it is filtered, obtain settled solution;Concentration is that the aqueous solution of 4mol/L hydrochloric acid adjusts the pH value of settled solution to 6, Add absolute ethyl alcohol and obtain mixture, and the weight/mass percentage composition of the ethanol in mixture is 72%, then filters, obtains sulfuric acid Chondroitin sodium.
(2) aqueous solution for the sodium chondroitin sulfate that weight/mass percentage composition is 10% is crossed into cation exchange resin column, works as stream The pH value for going out liquid collects efflux since neutrality is changed into 4.5, until the pH value of efflux is changed into 6.5, stops collecting.Wherein, The mass ratio of cationic ion-exchange resin and sodium chondroitin sulfate in cation exchange resin column is 3.5:1.
(3) use quality percentage composition be 15% strontium hydroxide the pH value of efflux collected of aqueous solution regulation to 6, Then Strontium Ranelate is added, stirring and dissolving 30 minutes, through standing reaction 4 hours, obtains reaction solution, wherein, Strontium Ranelate and sulphur The mass ratio of aching and limp ossein sodium is 0.6:1.
(4) aqueous solution that the ethanol that weight/mass percentage composition is 95% is added in reaction solution obtains mixed liquor, and mixed liquor In ethanol weight/mass percentage composition be 60%, by mixed liquor stand 14 hours, then filter, using absolute ethyl alcohol to filter thing Cleaning 3 times, then it is dried in vacuo 3 hours in 70 DEG C, it is H to obtain molecular formula2O(C14H19NSrO14S)100Chondroitin sulfate strontium.
The purity of the chondroitin sulfate strontium of the present embodiment is 96%.
Embodiment 4
The preparation process of the chondroitin sulfate strontium of the present embodiment is as follows:
(1) preparation of sodium chondroitin sulfate:By animal cartilage in deionized water 80 DEG C of boilings 3 hours, after removing grease, 100 DEG C of boilings 2 hours in deionized water, are dried after cooling.
Crushed after cartilage degreasing, obtain cartilage powder, cartilage powder is placed in retort, add going for 5 times of cartilage Ionized water mixes, and is then 0.4 according to the mass ratio of sodium acid carbonate and cartilage:1, sodium acid carbonate is added, is stirred in 40 DEG C to soft Bone powder dissolves, and obtains Cartilage solution;The pH value of the aqueous solution regulation Cartilage solution for the hydrochloric acid that concentration is 3mol/L is 9, is pressed It is 0.0050 according to the mass ratio of pancreatin and cartilage:1, pancreatin is added, is digested 4 hours in 40 DEG C, then be warming up to 80 DEG C of insulation reactions 4 Hour, it is filtered, obtain settled solution;Concentration is that the aqueous solution of 3mol/L hydrochloric acid adjusts the pH value of settled solution to 6, Add absolute ethyl alcohol and obtain mixture, and the weight/mass percentage composition of the ethanol in mixture is 75%, then filters, obtains sulfuric acid Chondroitin sodium.
(2) aqueous solution for the sodium chondroitin sulfate that weight/mass percentage composition is 6% is crossed into cation exchange resin column, works as outflow The pH value of liquid collects efflux since neutrality is changed into 4.8, until the pH value of efflux is changed into 6.8, stops collecting.Wherein, it is positive The mass ratio of cationic ion-exchange resin and sodium chondroitin sulfate in ion exchange resin column is 3:1.
(3) use quality percentage composition be 10% strontium hydroxide the aqueous solution regulation collect efflux pH value to 6.5, Strontium Ranelate is then added, stirring and dissolving 50 minutes, through standing reaction 2.5 hours, obtains reaction solution, wherein, thunder Buddhist nun acid The mass ratio of strontium and sodium chondroitin sulfate is 0.7:1.
(4) aqueous solution that the ethanol that weight/mass percentage composition is 95% is added in reaction solution obtains mixed liquor, and mixed liquor In ethanol weight/mass percentage composition be 65%, by mixed liquor stand 13 hours, then filter, using absolute ethyl alcohol to filter thing Cleaning 3 times, then it is dried in vacuo 4 hours in 60 DEG C, it is H to obtain molecular formula2O(C14H19NSrO14S)90Chondroitin sulfate strontium.
The purity of the chondroitin sulfate strontium of the present embodiment is 95%.
As a result detect:
Sodium chondroitin sulfate and the chondroitin sulfate strontium of embodiment 1 are subjected to mRNA detection of expression.
Osteoarthritis is the chronic joint disease that articular cartilage degeneration is characterized, and Osteoarthritis cartilage cell epimatrix closes Into with to degrade unbalance be one of major reason for causing cartilage degeneration.Wherein, matrix metalloproteinase is to cartilage cell epimatrix There is degradation, make arthroncus, external force resistance effect declines, and ultimately results in articular cartilage damage.And due to interleukin (IL-1 β) Can inducer substance metalloprotein expression of enzymes, and promote its activation, so as to cause cartilage matrix to be degraded.Memebrane protein (RANKL) is Memebrane protein on Gegenbaur's cell film, osteoclast can be activated, prevents osteoclast apoptosis.And collagen (CollagenI) It is the important component of articular cartilage.Therefore, by detecting interleukin (IL-1 β), collagen (CollagenI) and film egg The mRNA of (RANKL) relative expression quantity obtains the effect of sodium chondroitin sulfate and chondroitin sulfate strontium in vain.
MRNA relative expression quantities are detected using quantitative real time PCR Instrument (ABI, Vii A7), detect the reagent used For RNAiso Plus (TaKaRa, D9108A) and SYBR Green dye method mRNA detection kits (Geneup).Specific method For:Material to be detected (chondroitin sulfate strontium or sodium chondroitin sulfate) is added in the DMEM culture mediums containing 10%FBS respectively The culture solution for the material to be detected that concentration is 1mmol/L, 3mmol/L and 5mmol/L is configured to, without chondroitin sulfate strontium Every group in triplicate as a control group for DMEM culture mediums (containing 10%FBS);After cultivating 48 hours respectively, extracted with Trizol total RNA, reverse transcription obtain 4 cDNA samples;Then interleukin (IL-1 β), the collagen in 4 cDNA are detected respectively (CollagenI) and memebrane protein (RANKL) mRNA relative expression quantities.
Fig. 2 represent be embodiment 1 chondroitin sulfate strontium concentration be respectively 0mmol/L, 1mmol/L, 3mmol/L and The relative expression quantity of interleukin (IL-1 β) mRNA during 5mmol/L;What Fig. 3 was represented is the dense of the chondroitin sulfate strontium of embodiment 1 The relative expression of collagen (CollagenI) mRNA when degree is respectively 0mmol/L, 1mmol/L, 3mmol/L and 5mmol/L Amount;Fig. 4 represent be embodiment 1 chondroitin sulfate strontium concentration be respectively 0mmol/L, 1mmol/L, 3mmol/L and The relative expression quantity of memebrane protein (RANKL) mRNA during 5mmol/L.What Fig. 5 was represented is that the concentration of sodium chondroitin sulfate is respectively The relative expression quantity of interleukin (IL-1 β) mRNA when 0mmol/L, 1mmol/L, 3mmol/L and 5mmol/L;Fig. 6 represent be The collagen when concentration of sodium chondroitin sulfate is respectively 0mmol/L, 1mmol/L, 3mmol/L and 5mmol/L (CollagenI) mRNA relative expression quantity;What Fig. 7 was represented is that the concentration of sodium chondroitin sulfate is respectively 0mmol/L, 1mmol/ L, memebrane protein during 3mmol/L and 5mmol/L (RANKL) mRNA relative expression quantity.
From Fig. 2~7 as can be seen that with the increase of chondroitin sulfate strontium or the concentration of sodium chondroitin sulfate, interleukin (IL-1 β) mRNA relative expression quantity gradually decreases, and collagen (CollagenI) mRNA relative expression quantity gradually increases, Memebrane protein (RANKL) mRNA relative expression quantity gradually decreases.And compared with the sodium chondroitin sulfate of same concentrations, although sulfuric acid The relative expression quantity of the interleukin (IL-1 β) of chondroitin strontium is more or less the same, but collagen (CollagenI) mRNA relative table Significantly increased up to amount, and the relative expression quantity of memebrane protein (RANKL) also considerably reduces, it is clear that the property of chondroitin sulfate strontium Sodium chondroitin sulfate can be better than, chondroitin sulfate strontium being capable of preferably auxiliary treatment arthritis and osteoporosis.
Embodiment described above only expresses the several embodiments of the present invention, and its description is more specific and detailed, but simultaneously Therefore the limitation to the scope of the claims of the present invention can not be interpreted as.It should be pointed out that for one of ordinary skill in the art For, without departing from the inventive concept of the premise, various modifications and improvements can be made, these belong to the guarantor of the present invention Protect scope.Therefore, the protection domain of patent of the present invention should be determined by the appended claims.

Claims (1)

1. a kind of preparation method of chondroitin sulfate strontium, it is characterised in that comprise the following steps:
(1) preparation of sodium chondroitin sulfate:By animal cartilage in deionized water 100 DEG C of boilings 2 hours, after removing grease, then 100 DEG C of boilings 2 hours in deionized water, are dried after cooling;
Cartilage crushed after being dried, obtains cartilage powder, and cartilage powder is placed in retort, adds the deionized water of 30 times of cartilage Mixing, it is then 0.5 according to the mass ratio of sodium acid carbonate and cartilage:1, sodium acid carbonate is added, in 30 DEG C of stirrings to cartilage powder Dissolving, obtains Cartilage solution;Concentration be 4mol/L hydrochloric acid the aqueous solution adjust Cartilage solution pH value to 9, according to pancreatin Mass ratio with cartilage is 0.0055:1, pancreatin is added, is digested 5 hours in 50 DEG C, then it is warming up to 100 DEG C of insulation reactions 2 hours, It is filtered, obtain settled solution;Concentration be 4mol/L hydrochloric acid the aqueous solution adjust settled solution pH value to 6.5, add Enter absolute ethyl alcohol and obtain mixture, and the weight/mass percentage composition of the ethanol in mixture is 75%, then filters, it is soft to obtain sulfuric acid Ossein sodium;
(2) aqueous solution for the sodium chondroitin sulfate that weight/mass percentage composition is 5% is crossed into cation exchange resin column, when efflux PH value collects efflux since neutrality is changed into 5, until the pH value of efflux is changed into 6.5, stops collecting, wherein, cation is handed over The cationic ion-exchange resin and the mass ratio of sodium chondroitin sulfate changed in resin column is 4:1;
(3) use quality percentage composition be 20% strontium hydroxide the pH value of efflux collected of aqueous solution regulation to 6.5, so After add strontium chloride, stirring and dissolving 60 minutes, through standing reaction 5 hours, obtain reaction solution, wherein, strontium chloride and chondroitin sulfate The mass ratio of plain sodium is 0.8:1;
(4) aqueous solution that the ethanol that weight/mass percentage composition is 95% is added in reaction solution obtains mixed liquor, and in mixed liquor The weight/mass percentage composition of ethanol is 65%, and mixed liquor is stood into 15 hours, then filtered, and is cleaned using absolute ethyl alcohol to filtering thing 3 times, then it is dried in vacuo 2 hours in 80 DEG C, it is H to obtain molecular formula2O(C14H19NSrO14S)80Chondroitin sulfate strontium.
CN201510150350.0A 2015-03-31 2015-03-31 Chondroitin sulfate strontium and preparation method thereof Active CN104788586B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510150350.0A CN104788586B (en) 2015-03-31 2015-03-31 Chondroitin sulfate strontium and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510150350.0A CN104788586B (en) 2015-03-31 2015-03-31 Chondroitin sulfate strontium and preparation method thereof

Publications (2)

Publication Number Publication Date
CN104788586A CN104788586A (en) 2015-07-22
CN104788586B true CN104788586B (en) 2018-03-09

Family

ID=53553806

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510150350.0A Active CN104788586B (en) 2015-03-31 2015-03-31 Chondroitin sulfate strontium and preparation method thereof

Country Status (1)

Country Link
CN (1) CN104788586B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105440088B (en) * 2015-11-20 2019-02-12 南方科技大学 Glucosamine mixes strontium salt and its preparation method and application
CN108383927B (en) * 2018-04-11 2021-06-08 南方科技大学 Chondroitin sulfate magnesium and preparation method thereof
CN110604742B (en) * 2019-08-02 2021-12-03 南方科技大学 Eucommia polysaccharide strontium complex and preparation method and application thereof
CN113583406B (en) * 2021-08-03 2022-12-09 南方科技大学 Composite polyether-ether-ketone material and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008502609A (en) * 2004-06-17 2008-01-31 オステオロジックス エイ/エス Methods for improving treatment of rheumatoid arthritis and joint diseases
CN100497651C (en) * 2006-12-05 2009-06-10 中国水产科学研究院南海水产研究所 Sturgon chondrine extracting process
CN101831004A (en) * 2010-03-24 2010-09-15 章云 Hyaluronic acid strontium salt compounds, preparation method thereof and application in medicine
CN104451931A (en) * 2014-12-10 2015-03-25 东华大学 Method for preparing rare earth polysaccharide composite fibers

Also Published As

Publication number Publication date
CN104788586A (en) 2015-07-22

Similar Documents

Publication Publication Date Title
CN104788586B (en) Chondroitin sulfate strontium and preparation method thereof
CN105601731B (en) Purify the method for ox heel string collagen and its preparation of sponge
CN107376666B (en) A kind of modified cellulose acetate film and the preparation method and application thereof
CN104387617B (en) A kind of preparation method of corn straw modified cellulose gel
CN102516443B (en) Method for preparing super absorbent resin
CN104558238B (en) Process for extracting sodium alginate
CN104788510A (en) Method for extracting glucosamine from self-fermentation liquid
KR102591794B1 (en) Method for producing polypentosan sulfate
CN108939941B (en) A kind of PVDF flat-plate separation film with anticoagulant functions
CN103073652A (en) Method for extracting polysaccharide of spirulina platensis
CN102286252A (en) Process for producing gelatin by using acid method
CN109879985A (en) A kind of preparation method of medicinal small molecule pectin
CN100591696C (en) Method for separation purifying hyaluronic acid
CN104327747B (en) A kind of enzyme process prepares the production method of pharmagel
CN106032546A (en) Method for extracting medical material-based collagen from fish scales
CN110028624A (en) Preparation method and application based on hemicellulose compound temperature-sensitive gel
CN109467622A (en) A method of extracting heparin sodium from intestinal mucosa
CN102586213B (en) Method for extracting bromelain ananase through chitosan carboxylation derivative
CN105692845B (en) A kind of preparation method of the natural coagulant of pomelo peel
CN104829782A (en) Preparation method of polymeric flocculant
CN102492166B (en) Method for preparing feather keratin sponge by using feathers
CN108217892A (en) A kind of preparation method of cellulose-chitosan green flocculation material for the processing fabric dyeing waste water of multicomponent containing silk
CN109021095B (en) A kind of high-purity is without fishy smell algae blue pigment and the preparation method and application thereof
CN104945539B (en) Energy-saving low-temperature extracts heparin sodium technique
CN104017073A (en) Method for preparing collagen

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant